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data on mRNA expression showed that allograft cartilage tissues express
cartilage speciﬁc markers.
Conclusions: The colonization of human viable knee and ankle allografts
by recipient cells was investigated by genetic typing and mRNA
expression. There is an evidence of persistence of donor cells particularly
in knee allografts. This event is rare in ankle allografts, where the
prevailing presence of host DNA suggests the ingrowth of recipient cells
into the allograft, presumably migrating from the subchondral bone, in
accordance with histological ﬁndings. The observed synthesis of cartilage
speciﬁc RNAs in some of the analysed samples argues for the acquisition
of a chondrocyte-like phenotype by some of these cells.
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HYMOVIS™, A HEXADECYLAMIDE HYALURONAN DERIVATIVE
(HYADD®4-G), INHIBITS GENE EXPRESSION CHANGES INDUCED BY
INTERLEUKIN-1b IN CHONDROCYTES AND SYNOVIAL FIBROBLASTS
DERIVED FROM OSTEOARTHRITIS PATIENTS
M.M. Smith1, A.K. Russell1, A. Schiavinato2, C.B. Little1. 1Kolling Inst.
(Univ. of Sydney), Royal North Shore Hosp., St Leonards, NSW, Australia;
2Fidia SpA, Abano Terme, Italy
Osteoarthritis (OA) involves pathological change in all joint tissues,
including cartilage degradation and synovitis. Synovial changes are
associated with pain, while cartilage loss is a major indication for
joint replacement. Cycloxygenase-2 (PTGS2) and inﬂammatory cytokines
(IL6, TNF) are implicated in pain and increasing degradative enzymes
and cartilage breakdown. A Cochrane study suggested positive clinical
beneﬁts of intra-articular hyaluronan (HA), despite its brief joint
residency time. An amide-derivative of HA (HYMOVIS™) with increased
joint retention was superior to native HA in improving gait, reducing
synovial hyperplasia and cartilage MMP13 expression in a sheep OA
model. To elucidate the mechanism of the improved in vivo effects with
the chemically modiﬁed HA, the effects of HYMOVIS™ on chondrocytes
and synoviocytes from OA patients were evaluated.
Chondrocytes (HAC, n = 6) and synoviocytes (HSF, n = 6) were isolated
from OA patients at the time of knee replacement. HYMOVIS™ or native
HA (0, 0.5, 1.0 or 1.5mg/mL) was added to primary HAC or early passage
HSF with interleukin-1b (IL1b, 2 ng/mL). Cultures were terminated
30 minutes later for Bioplex® quantitation of phosphoproteins (p-JNK,
p-NFúB, p-p38), or 24 hours later for RNA isolation and analysis of gene
expression by real time RT-PCR, and measurement of MMP13 activity in
the media. Only statistically signiﬁcant results are reported.
In both HAC and HSF IL1b increased expression of MMP1, MMP13, PTGS2,
IL6 (>100fold), all phosphoproteins (3–10fold) and MMP13 activity. Cell
speciﬁc effects were seen with IL1b increasing expression of ADAMTS4
in HAC; ADAMTS5 in HSF (~10fold); and causing a 2–3fold reduction of
mRNA for COL2A1 and ACAN in HAC and COL1A1 in HSF.
In both cell types, HYMOVIS™ added with IL1b decreased MMP13,
ADAMTS4, ADAMTS5, PTGS2, IL6 expression, normalized matrix protein
expression, but had no effect on phosphoproteins. Cell-type speciﬁc
effects included decreased MMP1 expression only in HSF, and reduced
MMP13 activity only in HAC. In HAC, HYMOVIS™ preincubation was
superior to simultaneous addition in reducing ADAMTS, MMP, PTGS2,
and IL6 expression, but it also inhibited expression of TIMP1 and TIMP3,
and abrogated the rescue of COL2A1 and ACAN expression. There was a
less dramatic effect of HYMOVIS™ preincubation on gene expression in
HSF compared with HAC.
These results demonstrated a signiﬁcant beneﬁcial effect of the
HA derivative, HYMOVIS™, on both synoviocyte and chondrocyte
metabolism in vitro. This suggests HYMOVIS™ may have broader
OA disease modifying actions and clinical beneﬁt by reducing the
negative effects of degradative enzymes and inﬂammatory cytokines
in comparison to native HA.
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EFFECTS OF SURGERY AND POST-OPERATIVE INTRA-ARTICULAR
CORTICOSTEROIDS ON SYNOVIAL FLUID COLLAGEN BIOMARKERS
IN AN EQUINE MODEL OF OSTEOARTHRITIS
J.M. Manfredi1, T.N. Trumble1, M. Boyce1, D. Groschen1, K.A. Merritt2,
M.P. Brown2. 1Univ. of Minnesota Coll. of Vet. Med., St Paul, MN, USA;
2Univ. of Florida Coll. of Vet. Med., Gainesville, FL, USA
Purpose: Little is known about collagen metabolism in the joint after
surgery and how anti-inﬂammatory drugs affect this metabolism. The
purpose of this study was to investigate the effects of arthroscopic
surgery and post-surgical intra-articular administration of triamcinolone
acetonide (TA) on collagen synovial ﬂuid biomarkers using an animal
model of osteoarthritis. We hypothesized that collagen synthesis and
degradation would increase in synovial ﬂuid after arthroscopic removal
of osteochondral fragments, and that there would be greater collagen
degradation in the TA treated group than in saline controls.
Methods: In 7 normal adult Quarter Horses an osteochondral fragment
was arthroscopically created on the dorsal medial aspect of the ﬁrst
phalanx in one randomly chosen metacarpophalangeal joint (MCPJ).
MCPJ synovial ﬂuid was collected on weeks 0 (fragment creation), 16
(fragment removal), 17, 18, and 20. After ﬂuid collection on week 17,
horses were divided into 2 treatment groups: (1) horses (n = 4) that
received 1mL TA (10mg) and (2) horses (n = 3) that received 1mL saline
injected into the MCPJ from which the fragment was removed. Effects of
surgery and TA treatment were evaluated in week 18 and 20 samples.
Injured MCPJ synovial ﬂuid CPII, C12C, C2C (IBEX Technologies), and CTXII
(IDS/Nordic) concentrations were evaluated using commercially available
ELISAs previously validated for equine use. Synovial ﬂuid biomarker
concentrations for all weeks were compared to each other using unpaired
t-tests. P< 0.05 was considered signiﬁcant.
Fig. 1. Mean±SD synovial ﬂuid biomarker concentrations for CP II (A),
C12C (B), C2C (C), and CTX II (D). Week 0 = osteochondral (OC) fragment
creation; week 16 = OC fragment removal (Sx); week 17 = 1 week
post OC fragment removal followed by intra-articular injection (arrow –
Tx Admin) of either triamcinolone acetonide (TA) or saline; week 18 =
2 weeks post OC fragment removal and 1 week post TA (black bar) or
saline (gray bar) injection; week 20 = 4 weeks post OC fragment removal
and 3 weeks post TA (black bar) or saline (gray bar) injection. Different
letters indicate signiﬁcance differences (P < 0.05).
Results: Sixteen weeks after creation of an osteochondral fragment,
concentrations of CPII, C2C, C12C, and CTX II all signiﬁcantly increased
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above baseline (Figure 1). Surgery to remove osteochondral fragments at
week 16 did not result in any biomarker changes 1 week after surgery.
By week 18 there was a signiﬁcant increase in CTX II (P = 0.043) in the
saline control horses from week 17, and a trend towards increasing
concentrations of C2C (P = 0.11), C12C (P = 0.06), and CPII (P = 0.051).
By week 20, biomarker concentrations of CPII, C12C and CTX II had
decreased to week 16 pre-surgical concentrations in the saline control
horses. C2C however had signiﬁcantly increased concentrations from
week 17 and 18. One week (week 18) after injection with TA, C2C,
C12C, and CPII concentrations were all signiﬁcantly increased compared
to saline controls. In contrast, CTX II was signiﬁcantly lower than saline
controls (Figure 1). By 3 weeks (week 20) after TA injection, CPII and C12C
concentrations were no different than saline controls or week 16 pre-
surgical values. However, C2C concentrations continued to increase and
CTX II concentrations were still signiﬁcantly lower than saline controls.
Conclusions: Arthroscopic surgery to remove osteochondral fragments
did not affect collagen biomarkers by 1 week after surgery. By 2 weeks
after surgery (1 week after saline injection), overall metabolism increased
(CPII, C12C, and CTX II), which may be a delayed effect of surgery or in
response to saline injection. Intra-articular corticosteroid injection post-
operatively produced different responses in each biomarker, with both
catabolic and anabolic effects. After 1 week, CPII, C12C, and C2C were
increased, but by 3 weeks after administration, it appeared that the
joint was starting to become more catabolic with CPII concentrations
decreasing and C2C concentrations increasing. This suggests that TA
administration does not down regulate all collagenase activity in the
joint. TA dramatically decreased CTX II concentrations similarly to
ibuprofen which may be due to cathepsin K inactivation. Further
biomarker studies are needed to determine the affect of surgery and
intra-articular treatment on the joint.
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VISCOELASTIC PROPERTIES AND MOLECULAR WEIGHT OF HYLAN
G-F 20 COMPARED WITH OTHER COMMERCIAL HYALURONAN BASED
VISCOSUPPLEMENTS
L-P. Yu, H. Yang, E. Voschin, E. Skrabut. Genzyme Corp., Framingham, MA,
USA
Purpose: Visosupplementation with hyaluronan (HA)-based products
has been used clinically to provide relief of pain due to osteoarthritis.
This study compared the rheological properties and molecular weight
(MW) of hylan G-F 20 (Synvisc® or Synvisc-One®) to several commercially
available HA containing viscosupplements (VS). The percent elasticity
was evaluated as a function of molecular weight. Analgesic properties of
VS products are believed to be at least partially a function of elasticity
within the joint space.
Methods: Viscoelasticity was studied using a controlled stress rheometer
in the frequency range of 0.04–7Hz at 25°C. The percent elasticity
was calculated as a function of the elastic and viscous moduli. The
viscosity at shear rate 1 sec−1 (h(1)) was also determined. Size exclusion
chromatography (SEC) with multi-angle laser light scattering (MALLS)
was used to provide a direct determination of average molecular weight
(MW) and concentration of soluble HA. Each VS was diluted and
centrifuged to separate the gel phase (if any), then the supernatant
was analyzed by SEC/MALLS.
Results: The viscoelastic properties, percent elasticity, gel/ﬂuid
concentrations, and soluble HA MW for the VS products are listed in
the table below. Values for human synovial ﬂuid, obtained from the
literature, are also listed. Hylan G-F 20 shows much higher viscoelasticity
as demonstrated by its low crossover frequency (<0.01Hz), low phase
angle (<25°), and much higher shear viscosity and percent elasticity. Of
the products tested, Synvisc also showed the highest percent elasticity,
being similar to healthy young synovial ﬂuid. All products, except
Monovisc™, have similar total HA concentration; however, hylan G-F
20 had the highest soluble (ﬂuid) HA average MW (5.5 million) whereas
the other products had a MW of 1.6 million or less. The effect of HA MW
on product’s elasticity has been evaluated. As shown in the ﬁgure below,
the percent elasticity has a strong correlation with MW, and is less
affected by the HA concentration. Thus Monovisc, containing twice the
concentration of soluble HA, showed only 47% elasticity due to its low HA
MW. On the other hand, normal young synovial ﬂuid, which contained
less than 5mg/ml HA, still showed 72% elasticity. These results suggest
that when rheology, MW and concentration are considered together,
hylan G-F 20 has aggregate physicochemical properties most similar to
healthy young synovial ﬂuid.
Conclusion: The molecular weight of hylan G-F 20 is substantially
higher than the other viscosupplements tested. Low molecular weight
viscosupplements demonstrated a percent elasticity less than half of
that observed for hylan G-F 20. When injected intra-acticularly, high
percent elasticity and high viscosity are critical for shock absorption and
lubrication in the joint. The inclusion of high MW HA in Synvisc resulted
in viscoelastic properties more similar to healthy young synovial ﬂuid.
Figure: Effect of HA MW on % elasticity.
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RESULTS OF SUBJECTIVE (CLINICAL) AND OBJECTIVE EVALUATION
(NIRS-MEASUREMENTS) OF CARTILAGE LESIONS IN KNEE
ARTHROSCOPY
G. Spahn1, H.M. Klinger2, M. Baums2, U. Pinkepank1, G.O. Hofmann3.
1Ctr. of Traumatology and Orthopaedic Surgery, Eisenach, Germany; 2Ctr.
of Orthopaedic Surgery Univ. of Goettingen, Goettingen, Germany; 3Ctr.
of Trauma Univ. of Jena and Trauma Ctr. Bergmannstrost Halle, Eisenach,
Germany
Aim: To detect the inter-observer variance of arthroscopic cartilage
grading by subjective judgment using the ICRS (International Cartilage
Repair Society) score and by objective measurement using NIRS (near-
infrared spectroscopy).
It was hypothesized that objective measurement of cartilage lesions by
NIRS yielded more valid results than routine grading utilizing the ICRS
score.
Methods: Fifteen patients who had undergone arthroscopic knee
operations were evaluated by four experienced arthroscopists. The
cartilage lesions within the medial knee compartment were estimated
observer-independently by using the ICRS grade and by measurements
with a special arthroscopic NIRS-probe.
Results: The ICRS grading had a poor inter-observer agreement, with a
mean Fleiss-Kappa-Index of K =0.173. Only in a total of six from sixty
(10.0%) judged cartilage areas did all four surgeons grade the cartilage
areas with the same result. In 17 areas (28.3%), the surgeons had a
variance of two or more grades. In the residuary cases, the surgeons
varied within one grade.
The objective NIRS-obtained measurements of cartilage resulted in
a signiﬁcant correlation within the observers of R =0.885±0.036;
p < 0.001.
Conclusion: Our results of inter-observer evaluation in real-time
arthroscopic cartilage grading suggest that this subjective grading is not
satisfactory. This study emphasizes the need for objective measurement
techniques for an evident arthroscopic cartilage grading. Near-infrared
spectroscopy (NIRS) has a good inter-observer correlation. Thus, this
